Multiple powerful forces propel the Sertraline Hydrochloride Tablet Market forward globally. The worldwide mental health epidemic, exacerbated by post-pandemic psychological impacts, has dramatically increased depression and anxiety diagnoses. The Sertraline Hydrochloride Tablet Market benefits from sertraline's favorable safety profile compared to older tricyclic antidepressants, reducing barriers to initiation. Expanded healthcare coverage and mental health parity legislation improve treatment accessibility across demographics. Generic availability has substantially reduced costs, enabling broader population access in both developed and developing markets. Physician familiarity and extensive clinical experience with sertraline sustain prescribing confidence. Off-label applications for premenstrual dysphoric disorder and premature ejaculation extend market utility. Growing geriatric populations, vulnerable to late-life depression, create additional demand segments. Pharmaceutical companies continue investing in improved formulations and combination therapies.